1.1 	A bill for an act
1.2 	relating to health insurance; requiring coverage of vasectomies by health plans; 
1.3 	requiring the medical assistance program and MinnesotaCare to cover vasectomies;
1.4 	amending Minnesota Statutes 2024, sections 62Q.522, subdivision 1; 256B.0625, 
1.5 	by adding a subdivision.
1.6 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.7 	Section 1. Minnesota Statutes 2024, section 62Q.522, subdivision 1, is amended to read:
1.8 		Subdivision 1.Definitions. (a) The definitions in this subdivision apply to this section.
1.9 	(b) "Contraceptive method" means a drug, device, or other product approved by the 
1.10 	Food and Drug Administration to prevent unintended pregnancy.
1.11 	(c) "Contraceptive service" means consultation, examination, procedures, and medical 
1.12 	services related to the prevention of unintended pregnancy, excluding vasectomies. This 
1.13 	includes but is not limited to voluntary sterilization procedures, patient education, counseling 
1.14 	on contraceptives, and follow-up services related to contraceptive methods or services, 
1.15 	management of side effects, counseling for continued adherence, and device insertion or 
1.16 	removal.
1.17 	(d) "Medical necessity" includes but is not limited to considerations such as severity of 
1.18 	side effects, difference in permanence and reversibility of a contraceptive method or service, 
1.19 	and ability to adhere to the appropriate use of the contraceptive method or service, as 
1.20 	determined by the attending provider.
1.21 	(e) "Therapeutic equivalent version" means a drug, device, or product that can be expected 
1.22 	to have the same clinical effect and safety profile when administered to a patient under the 
1.23 	conditions specified in the labeling, and that:
2.1 	(1) is approved as safe and effective;
2.2 	(2) is a pharmaceutical equivalent: (i) containing identical amounts of the same active 
2.3 	drug ingredient in the same dosage form and route of administration; and (ii) meeting 
2.4 	compendial or other applicable standards of strength, quality, purity, and identity;
2.5 	(3) is bioequivalent in that:
2.6 	(i) the drug, device, or product does not present a known or potential bioequivalence 
2.7 	problem and meets an acceptable in vitro standard; or
2.8 	(ii) if the drug, device, or product does present a known or potential bioequivalence 
2.9 	problem, it is shown to meet an appropriate bioequivalence standard;
2.10 	(4) is adequately labeled; and
2.11 	(5) is manufactured in compliance with current manufacturing practice regulations.

2.12 	EFFECTIVE DATE. This section is effective January 1, 2026, and applies to health 
2.13 	plans offered, issued, or renewed on or after that date.

2.14 	Sec. 2. Minnesota Statutes 2024, section 256B.0625, is amended by adding a subdivision 
2.15 	to read:
2.16 		Subd. 77.Vasectomies. (a) Medical assistance covers vasectomies.
2.17 	(b) Medical assistance must meet the requirements with respect to coverage of 
2.18 	vasectomies that would otherwise apply to a health plan under section 62Q.522, except that 
2.19 	medical assistance is not required to comply with any provision of section 62Q.522 if 
2.20 	compliance with the provision would:
2.21 	(1) prevent the state from receiving federal financial participation for the coverage under 
2.22 	this subdivision;
2.23 	(2) result in a lower level of coverage or reduced access to coverage for medical assistance 
2.24 	enrollees; or
2.25 	(3) violate Code of Federal Regulations, title 42, part 441, subpart F.

2.26 	EFFECTIVE DATE. This section is effective January 1, 2026, or upon federal approval, 
2.27 	whichever is later. The commissioner of human services shall notify the revisor of statutes 
2.28 	when federal approval is obtained.